These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 19618727

  • 1. [Pharmacokinetics of rhGH decorated by polyethylene glycol in rat in vivo].
    Jiang L, Cai YM, Zeng Y, Huang J, Chen ZM.
    Yao Xue Xue Bao; 2009 May; 44(5):506-9. PubMed ID: 19618727
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
    Hou L, Chen ZH, Liu D, Cheng YG, Luo XP.
    Drug Des Devel Ther; 2016 May; 10():13-21. PubMed ID: 26719670
    [Abstract] [Full Text] [Related]

  • 3. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J, Wu F, Cai Y, Xu M, He M, Yuan W.
    Eur J Pharm Sci; 2014 Oct 01; 62():141-7. PubMed ID: 24907681
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
    Nemirovskiy O, Zheng YJ, Tung D, Korniski B, Settle S, Skepner A, Yates M, Aggarwal P, Sunyer T, Aguiar DJ.
    Xenobiotica; 2010 Aug 01; 40(8):586-92. PubMed ID: 20509748
    [Abstract] [Full Text] [Related]

  • 5. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y, Wang Y, Kang A, Wang W, Ho SV, Gao J, Ma G, Su Z.
    Mol Pharm; 2012 Jul 02; 9(7):2039-48. PubMed ID: 22663348
    [Abstract] [Full Text] [Related]

  • 6. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats.
    Zhang ZX, Liu YK, Pan H, Pan L, Zhang Q, Su HM, Zhao QL, Li H, He C.
    Growth Horm IGF Res; 2012 Feb 02; 22(1):30-5. PubMed ID: 22257554
    [Abstract] [Full Text] [Related]

  • 7. Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification.
    Karbasian M, Kouchakzadeh H, Anamaghi PN, Sefidbakht Y.
    Int J Pharm; 2019 Feb 25; 557():9-17. PubMed ID: 30576790
    [Abstract] [Full Text] [Related]

  • 8. A long-acting pegylated recombinant human growth hormone (Jintrolong® ) in healthy adult subjects: Two single-dose trials evaluating safety, tolerability and pharmacokinetics.
    Guan Y, He F, Wu J, Zhao L, Wang X, Huang L, Zeng G, Ren B, Chen J, Liao X, Ma Z, Chen X, Zhong G, Huang M, Zhao X.
    J Clin Pharm Ther; 2018 Oct 25; 43(5):640-646. PubMed ID: 29959799
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration.
    Keller A, Wu Z, Kratzsch J, Keller E, Blum WF, Kniess A, Preiss R, Teichert J, Strasburger CJ, Bidlingmaier M.
    Eur J Endocrinol; 2007 Jun 25; 156(6):647-53. PubMed ID: 17535864
    [Abstract] [Full Text] [Related]

  • 10. A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys.
    Sun YN, Lee HJ, Almon RR, Jusko WJ.
    J Pharmacol Exp Ther; 1999 Jun 25; 289(3):1523-32. PubMed ID: 10336548
    [Abstract] [Full Text] [Related]

  • 11. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats.
    Ito Y, Ohashi Y, Shiroyama K, Sugioka N, Takada K.
    Biol Pharm Bull; 2008 Aug 25; 31(8):1631-3. PubMed ID: 18670103
    [Abstract] [Full Text] [Related]

  • 12. Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution.
    Jacobsen LV, Rolan P, Christensen MS, Knudsen KM, Rasmussen MH.
    Growth Horm IGF Res; 2000 Apr 25; 10(2):93-8. PubMed ID: 10931747
    [Abstract] [Full Text] [Related]

  • 13. Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in Rats.
    Kawashima R, Uchida M, Yamaki T, Ohtake K, Hatanaka T, Uchida H, Ueda H, Kobayashi J, Morimoto Y, Natsume H.
    Biol Pharm Bull; 2016 Apr 25; 39(3):329-35. PubMed ID: 26725528
    [Abstract] [Full Text] [Related]

  • 14. Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres.
    Yu Z, Huang L, Wen R, Li Y, Zhang Q.
    Pharm Dev Technol; 2019 Apr 25; 24(4):395-401. PubMed ID: 30422727
    [Abstract] [Full Text] [Related]

  • 15. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S, Kurokawa T, Misaki M, Taira K, Yamagata Y.
    J Pharm Pharmacol; 2003 Jul 25; 55(7):951-61. PubMed ID: 12906752
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of PEG recombinant human interleukin-6 in rats].
    He XL, Yang G, Yin HL, Zhang XM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan 25; 40(1):149-52. PubMed ID: 19292067
    [Abstract] [Full Text] [Related]

  • 17. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
    Stanhope R, Sörgel F, Gravel P, Pannatier Schuetz YB, Zabransky M, Muenzberg M.
    J Clin Pharmacol; 2010 Nov 25; 50(11):1339-48. PubMed ID: 20173088
    [Abstract] [Full Text] [Related]

  • 18. Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine.
    Moore JA, Rudman CG, MacLachlan NJ, Fuller GB, Burnett B, Frane JW.
    Endocrinology; 1988 Jun 25; 122(6):2920-6. PubMed ID: 3371267
    [Abstract] [Full Text] [Related]

  • 19. Development of a sustained-release recombinant human growth hormone formulation.
    Kwak HH, Shim WS, Choi MK, Son MK, Kim YJ, Yang HC, Kim TH, Lee GI, Kim BM, Kang SH, Shim CK.
    J Control Release; 2009 Jul 20; 137(2):160-5. PubMed ID: 19332090
    [Abstract] [Full Text] [Related]

  • 20. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
    Luo X, Hou L, Liang L, Dong G, Shen S, Zhao Z, Gong CX, Li Y, Du ML, Su Z, Du H, Yan C.
    Eur J Endocrinol; 2017 Aug 20; 177(2):195-205. PubMed ID: 28566441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.